Our histone peptides are derived from human Histone H1, Histone H2A, Histone H2B, Histone H3 and Histone H4. Supplied in 0.5mg amounts, these peptides may contain various post-translational modifications or are biotinylated for immobilising on a suitable support. Ideal for epigenetic studies, binding studies or ELISA use, our peptides are purified by reverse phase HPLC and freeze-dried, ready for immediate shipping.
Our peptide synthesis specialists are continually adding to this stock list, so if you would like a histone peptide that isn’t currently listed, please contact us.
Each peptide is supplied in 0.5mg aliquots starting from £110 per aliquot.
For larger amounts, please contact us so we can provide a quotation.
Histone peptides from H2B
| Histone source | Modifications | Histone peptide sequence | Catalog no. | Quantity | Price |
| H2B(15-35) | K20ac biotin | KKAVT-K(ac)-AQKKDGKKRKRSRKE-ahx-K(Biotin)-amide | HS09 | 0.5 mg | £135 |
Histone peptides from H3
| Histone source | Modifications | Histone peptide sequence | Catalog no. | Quantity | Price |
| H3(1-21) | K4me2 biotin | ART-K(Me2)-QTARKSTGGKAPRKQLA-ahx-K(Biotin)-amide | HS04 | 0.5 mg | £135 |
| H3(1-21) | K9me biotin | ARTKQTAR-K(Me)-STGGKAPRKQLA-ahx-K(Biotin)-amide | HS05 | 0.5 mg | £135 |
| H3(1-21) | K4ac biotin | ART-K(ac)-QTARKSTGGKAPRKQLA-ahx-K(Biotin)-amide | HS06 | 0.5 mg | £110 |
| H3(1-21) | K9ac, K14ac biotin | ARTKQTAR-K(ac)-STGG-K(ac)-APRKQLA-ahx-K(Biotin)-amide | HS07 | 0.5 mg | £110 |
| H3(4-24) | biotin | acetyl-KQTARKSTGGKAPRKQLATKA-ahx-K(Biotin)-amide | HS08 | 0.5 mg | £110 |
| H3(8-28) | acetyl-RKSTGGKAPRKQLATKAARKS-ahx-K(Biotin)-amide | HS10 | 0.5 mg | £125 | |
| H3(20-40) | biotin | acetyl-LATKAARKSAPATGGVKKPHR-ahx-K(Biotin)-amide | HS14 | 0.5 mg | £110 |
| H3(14-34) | biotin-ahx | biotin-ahx-KAPRKQLATKAARKSAPATGG | HS15 | 0.5 mg | £110 |
| H3(1-21) | K9ac | ARTKQTAR-K(ac)-STGGKAPRKQLA | HS16 | 0.5 mg | £125 |
| H3(1-8) | K4me3 + GGC | ART-K(Me3)-QTARGGC-amide | HS18 | 0.5 mg | £135 |
| H3(14-34) | KAPRKQLATKAARKSAPATGG | HS19 | 0.5 mg | £125 | |
| H3(1-8) | + GGC | ART-K(Me)-QTARGGC-amide | HS22 | 0.5 mg | £135 |
| H3(13-30) | K23ac + ST biotin | GKAPRKQLAT-K(ac)-AARKSAPST–K(Biotin)-amide | HS24 | 0.5 mg | £110 |
| H3(51-61) | K56ac, biotin | biotin-IRRYQ-K(ac)-STELL | HS25 | 0.5 mg | £110 |
| H3(1-21) | biotin | ARTKQTARKSTGGKAPRKQLA-ahx-K(Biotin)-amide | HS27 | 0.5 mg | £110 |
| H3(1-21) | ARTKQTARKSTGGKAPRKQLA | HS28 | 0.5 mg | £125 | |
| H3(1-21) | K9me2, K14ac biotin | ARTKQTAR-K(Me2)-STGG-K(ac)-APRKQLA-ahx-K(Biotin)-amide | HS29 | 0.5 mg | £135 |
| H3(1-21) | K9me3, K14ac biotin | ARTKQTAR-K(Me3)-STGG-K(ac)-APRKQLA-ahx-K(Biotin)-amide | HS30 | 0.5 mg | £135 |
| H3(1-21) | K9ac biotin | ARTKQTAR-K(ac)-STGGKAPRKQLA-ahx-K(Biotin)-amide | HS31 | 0.5 mg | £110 |
| H3(11-31) | K23ac biotin | acetyl-TGGKAPRKQLAT-K(ac)AARKSAPA-ahx-K(Biotin)-amide | HS32 | 0.5 mg | £110 |
| H3(23-43) | K36ac biotin | acetyl-KAARKSAPATGGV-K(ac)-KPHRYRP-ahx-K(Biotin)-amide | HS33 | 0.5 mg | £110 |
| H3(1-21) | K9M | ARTKQTARMSTGGKAPRKQLA-ahx-K(Biotin)-amide | HS35 | 0.5 mg | £110 |
| H3(1-21) | K9ac, K14ac | ARTKQTAR-K(ac)-STGG-K(ac)-APRKQLA | HS37 | 0.5 mg | £125 |
| H3(1-21) | K9ac, K14ac | ARTKQTAR-K(ac)-STGG-K(ac)-APRKQLA-ahx-K-amide | HS38 | 0.5 mg | £125 |
| H3(1-40) | K14ac, K18ac biotin | ARTKQTARKSTGG-K(ac)-APR-K(ac)-QLATKAARKSAPATGGVKKPHR-ahx-K(Biotin)-amide | HS43 | 0.5 mg | £110 |
| H3(1-40) | biotin | ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKP HR -ahx-K(Biotin)-amide | HS44 | 0.5 mg | £110 |
| H3(1-21) | Ci2 biotin | A-Cit-TKQTARKSTGGKAPRKQLA-ahx-K(Biotin)-amide | HS45 | 0.5 mg | £110 |
| H3(1-21) | Ci8 biotin | ARTKQTA-Cit-KSTGGKAPRKQLA-ahx-K(Biotin)-amide | HS46 | 0.5 mg | £110 |
| H3(1-21) | Ci2, Ci8, Ci17 biotin | A-Cit-TKQTA-Cit-KSTGGKAP-Cit-KQLA-ahx-K(Biotin)-amide | HS47 | 0.5 mg | £110 |
| H3(12-38) | biotin | acetyl-GGKAPRKQLATKAARKSAPATGGVKKP-ahx-K(Biotin)-amide | HS48 | 0.5 mg | £110 |
| H3(1-21) | K9me3 | ARTKQTAR-K(Me3)-STGGKAPRKQLA | HS49 | 0.5 mg | £135 |
| H3(1-21) | K4me3 | ART-K(Me3)-QTARKSTGGKAPRKQLA | HS50 | 0.5 mg | £135 |
| H3(9-19) | K14ac + C | acetyl-KSTGG-K(ac)-APRKQC-amide | HS51 | 0.5 mg | £125 |
| H3(18-28) | K23ac + C | acetyl-KQLAT-K(ac)-AARKSC-amide | HS52 | 0.5 mg | Please enquire |
| H3(29-43) | K36me biotin | acetyl-APATGGV-K(Me)-KPHRYRP-ahx-K(Biotin)-amide | HS54 | 0.5 mg | £130 |
| H3(1-21) | K4me2 | ART-K(Me2)-QTARKSTGGKAPRKQLA | HS55 | 0.5 mg | £135 |
| H3(1-21) | K9me2 | ARTKQTAR-K(Me2)-STGGKAPRKQLA | HS56 | 0.5 mg | £135 |
| H3(1-21) | K14ac | ARTKQTARKSTGG-K(ac)-APRKQLA-ahx-K(Biotin)-amide | HS59 | 0.5 mg | Please enquire |
| H3(1-21) | K4me3 biotin | ART-K(Me3)-QTARKSTGGKAPRKQLA-ahx-K(Biotin)-amide | HS60 | 0.5 mg | £135 |
| H3(1-21) | K9me3 biotin | ARTKQTAR-K(Me3)-STGGKAPRKQLA-ahx-K(Biotin)-amide | HS61 | 0.5 mg | £145 |
| H3(1-21) | K14ac | ARTKQTARKSTGG-K(ac)-APRKQLA-ahx-amide | HS62 | 0.5 mg | Please enquire |
| H3(10-17) | K14ac | STGG-K(ac)-APR-ahx-amide | HS63 | 0.5 mg | £125 |
| H3(9-17) | K9ac, K14ac | K(ac)-STGG-K(ac)-APR-ahx-amide | HS64 | 0.5 mg | £130 |
| H3(8-17) | K9ac, K14ac | RK(ac)-STGG-K(ac)-APR-ahx-amide | HS65 | 0.5 mg | £130 |
Histone peptides from H4
| Histone source | Modifications | Histone peptide sequence | Catalog no. | Quantity | Price |
| H4(1-21) | K5ac, K8ac, K12ac, biotin | SGRG-K(ac)-GG-K(ac)-GLG-K(ac)-GGAKRHRKV-ahx-K(Biotin)-amide | HS01 | 0.5 mg | Please enquire |
| H4(1-21) | K5ac, K8ac, K12ac, biotin | SGRG-K(ac)-GG-K(ac)-GLG-K(ac)-GGAKRHRKV-K(Biotin)-amide | HS02 | 0.5 mg | £110 |
| H4(1-21) | SGRGKGGKGLGKGGAKRHRKV | HS03 | 0.5 mg | £110 | |
| H4(1-21) | K5ac, K12ac biotin | SGRG-K(ac)-GGKGLG-K(ac)-GGAKRHRKV-ahx-K(Biotin)-amide | HS11 | 0.5 mg | £110 |
| H4(1-21) | K5ac | SGRG-K(ac)-GGKGLGKGGAKRHRKV-amide | HS12 | 0.5 mg | £125 |
| H4(6-26) | K11ac, K15ac biotin | GGKGLG-K(ac)-GGA-K(ac)-RHRKVLRDNI-ahx-K(Biotin)-amide | HS13 | 0.5 mg | £110 |
| H4(1-21) | K12ac biotin | SGRGKGGKGLG-K(ac)-GGAKRHRKV-ahx-K(Biotin)-amide | HS17 | 0.5 mg | £110 |
| H4(1-21) | K5ac, K8ac, K12ac | SGRG-K(ac)-GG-K(ac)-GLG-K(ac)-GGAKRHRKV | HS20 | 0.5 mg | £125 |
| H4(1-21) | K5ac, K12ac | SGRG-K(ac)-GGKGLG-K(ac)-GGAKRHRKV | HS21 | 0.5 mg | £125 |
| H4(1-21) | K5ac | acetyl-SGRG-K(ac)-GGKGLGKGGAKRHRKV | HS23 | 0.5 mg | £125 |
| H4(1-20) | K12ac biotin | SGRGKGGKGLG-K(Ac)-GGAKRHRK | HS26 | 0.5 mg | £125 |
| H4(1-21) | K16ac biotin | SGRGKGGKGLGKGGA-K(ac)-RHRKV-ahx-K(Biotin)-amide | HS34 | 0.5 mg | £110 |
| H4(1-21) | K5ac | SGRG-K(ac)-GGKGLGKGGAKRHRKV | HS36 | 0.5 mg | £125 |
| H4(1-21) | K8ac, K12ac | SGRGKGG-K(ac)-GLG-K(ac)-GGAKRHRKV | HS39 | 0.5 mg | £125 |
| H4(1-21) | K8ac | SGRGKGG-K(ac)-GLGKGGAKRHRKV | HS40 | 0.5 mg | £125 |
| H4(1-21) | K5ac, K8ac | SGRG-K(ac)-GG-K(ac)-GLGKGGAKRHRKV | HS41 | 0.5 mg | £125 |
| H4(1-21) | K5ac, K8ac biotin | SGRG-K(ac)-GG-K(ac)-GLGKGGAKRHRKV-ahx-K(Biotin)-amide | HS42 | 0.5 mg | £110 |
| H4(1-19) | K5ac, K8ac, K12ac, K16ac + C | acetyl-SGRG-K(ac)-GG-K(ac)-GLG-K(ac)-GGA-K(ac)-RHRC-amide | HS53 | 0.5 mg | £125 |
| H4(9-29) | biotin | acetyl-GLGKGGAKRHRKVLRDNIQGI-ahx-K(Biotin)-amide | HS57 | 0.5 mg | £110 |
| H4(1-22) | SGRGKGGKGLGKGGAKRHRKVK | HS58 | 0.5 mg | Please enquire |
For bulk amounts of any of these peptides, please contact us for a quotation.
Not finding what you need? Contact us or visit our custom peptide synthesis page.
Related articles
Epitope Mapping: Methods, Applications and Peptide-Based Approaches
A practical guide to linear epitope mapping: how overlapping peptide libraries and microarrays map antibody and T-cell epitopes and how to get reliable data.
Investigating the Role of Zika Virus Small Membrane M Protein with Synthetic Peptides
Learn how our synthetic peptides enabled groundbreaking research into Zika virus infectivity and viroporin biology at the University of Leeds.
Fluorescent Peptides: A Guide for Life Science Researchers
Explore key considerations for designing fluorescent peptides, including dye selection, spacers, handling, and storage. Read our guide.
Peptide Synthesis: An Overview
Peptide synthesis is a cornerstone of modern science, underpinning advances in medicine, biotechnology, and fundamental research that enable the creation of molecules that drive advancements in medicine, research, and technology.
Peptide Oligonucleotide Conjugates for Life Science Research
The conjugation of peptides to oligos is highly advantageous. It broadens their applications by enhancing them with additional unique properties. Read more.